Akebia Therapeutics Inc (NASDAQ:AKBA)

10.65
Delayed Data
As of May 18
 +0.15 / +1.43%
Today’s Change
8.93
Today|||52-Week Range
20.25
-28.38%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close10.50
Today’s open10.52
Day’s range10.49 - 10.70
Volume317,001
Average volume (3 months)429,369
Market cap$593.3M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+50.83%
Earnings growth (this year)-11.95%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+11,495.05%
P/E ratioNM
Price/Sales3.63
Price/Book4.16

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.34+1.21%
AKAOAchaogen Inc-0.04-0.32%
SPPISpectrum Pharmaceuti...+0.15+0.75%
FLXNFlexion Therapeutics...+1.12+4.20%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$178.0M
Annual profit (last year)-$76.9M
Net profit margin-43.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
John P. Butler
Vice President-
Operations
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts